5DS — MegaChem Income Statement
0.000.00%
- SG$46.66m
- SG$60.94m
- SG$128.84m
- 85
- 86
- 74
- 96
Annual income statement for MegaChem, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 105 | 139 | 144 | 123 | 129 |
Cost of Revenue | |||||
Gross Profit | 26.5 | 34.1 | 34.4 | 22.5 | 31.2 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 100 | 131 | 136 | 127 | 119 |
Operating Profit | 5.07 | 8.37 | 8.09 | -4.47 | 9.38 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 5.94 | 9.19 | 7.83 | -5.34 | 8.69 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.26 | 7.99 | 6.07 | -5.8 | 7.91 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 5.13 | 7.76 | 5.88 | -5.91 | 7.91 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.13 | 7.76 | 5.88 | -5.91 | 7.91 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.032 | 0.056 | 0.044 | -0.048 | 0.055 |
Dividends per Share |